These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 24002148

  • 1. Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.
    Jarratt M, Siu WJ, Yamakawa E, Kodera N, Pillai R, Smith K.
    J Drugs Dermatol; 2013 Sep; 12(9):1010-6. PubMed ID: 24002148
    [Abstract] [Full Text] [Related]

  • 2. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R.
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [Abstract] [Full Text] [Related]

  • 3. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M, Sugimoto N, Kawabata H, Yamakawa E, Kodera N, Pillai R, Tatsumi Y.
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [Abstract] [Full Text] [Related]

  • 4. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF, Elewski B, Sugarman JL, Rosen T, Vlahovic TC, Gupta AK, Stein Gold L, Pillai R, Guenin E.
    J Drugs Dermatol; 2020 Sep 01; 19(9):867-872. PubMed ID: 33026753
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S.
    J Drugs Dermatol; 2014 Jul 01; 13(7):815-20. PubMed ID: 25007364
    [Abstract] [Full Text] [Related]

  • 6. Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.
    Jo W, Glynn M, Nejishima H, Sanada H, Minowa K, Calvarese B, Senda H, Pillai R, Mutter L.
    Regul Toxicol Pharmacol; 2014 Oct 01; 70(1):242-53. PubMed ID: 25038564
    [Abstract] [Full Text] [Related]

  • 7. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC, Joseph WS.
    J Drugs Dermatol; 2014 Oct 01; 13(10):1186-90. PubMed ID: 25607552
    [Abstract] [Full Text] [Related]

  • 8. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR, Scher RK.
    Expert Rev Clin Pharmacol; 2015 Oct 01; 8(6):719-31. PubMed ID: 26325488
    [Abstract] [Full Text] [Related]

  • 9. How effective is efinaconazole in the management of onychomycosis?
    Gupta AK, Cernea M.
    Expert Opin Pharmacother; 2016 Oct 01; 17(4):611-8. PubMed ID: 26809447
    [Abstract] [Full Text] [Related]

  • 10. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
    Tosti A.
    Cutis; 2013 Oct 01; 92(4):203-8. PubMed ID: 24195094
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efinaconazole 10% solution in the treatment of onychomycosis of the toenails.
    Joseph WS, Vlahovic TC, Pillai R, Olin JT.
    J Am Podiatr Med Assoc; 2014 Oct 01; 104(5):479-85. PubMed ID: 25275736
    [Abstract] [Full Text] [Related]

  • 13. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K, Sugimoto N, Hosaka S, Katafuchi-Nagashima M, Arakawa Y, Tatsumi Y, Jo Siu W, Pillai R.
    Antimicrob Agents Chemother; 2014 Jul 01; 58(7):3837-42. PubMed ID: 24752277
    [Abstract] [Full Text] [Related]

  • 14. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK, Simpson FC.
    Skin Therapy Lett; 2014 Jul 01; 19(1):1-4. PubMed ID: 24570290
    [Abstract] [Full Text] [Related]

  • 15. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA.
    J Am Podiatr Med Assoc; 2014 Nov 01; 104(6):568-73. PubMed ID: 25514267
    [Abstract] [Full Text] [Related]

  • 16. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Gupta AK, Studholme C.
    Skin Therapy Lett; 2016 Nov 01; 21(6):7-11. PubMed ID: 27825175
    [Abstract] [Full Text] [Related]

  • 17. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P.
    J Drugs Dermatol; 2015 Jan 01; 14(1):58-62. PubMed ID: 25607909
    [Abstract] [Full Text] [Related]

  • 18. Efinaconazole 10% nail solution: a post-FDA approval update.
    Gupta AK, Simpson FC, Abramovits W, Scheinfeld N.
    Skinmed; 2014 Jan 01; 12(4):235-7. PubMed ID: 25335353
    [No Abstract] [Full Text] [Related]

  • 19. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE, Pollak RA, Pillai R, Olin JT.
    J Drugs Dermatol; 2014 Nov 01; 13(11):1394-8. PubMed ID: 25607708
    [Abstract] [Full Text] [Related]

  • 20. Efinaconazole topical solution (Jublia) for onychomycosis.
    Med Lett Drugs Ther; 2014 Sep 15; 56(1451):88-9. PubMed ID: 25211303
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.